Search results for " malattie."

showing 10 items of 1941 documents

Metastatic Melanoma of the Tongue: A Rare Case

2012

Not available

medicine.medical_specialtyHistologyMetastatic melanomabusiness.industryMelanomaDermatologyGeneral Medicinemedicine.diseaseoral melanomaDermatologyPathology and Forensic Medicinemedicine.anatomical_structureSettore MED/28 - Malattie OdontostomatologicheTongueRare caseMedicineTongue NeoplasmbusinessActas Dermo-Sifiliográficas
researchProduct

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.

2020

Abstract Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control study, we recruited 647 patients with carcinoma, nonmelanoma skin cancer, hematological second cancer, and melanoma diagnosed concurrently or after MPN diagnosis. Up to 3 control patients without a history of cancer and matched with each case for center, sex, age at MPN diagnosis, date of diagnosis, and MPN disease duration were included (n = 1234). Cases were comparable to controls for MPN type, driver mutations and cardiovascular risk factors. The freque…

medicine.medical_specialtyImmunologyKaplan-Meier EstimateGene mutationBiochemistryGastroenterologyMyeloproliferative neoplasms03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicineCarcinomaMedicineHumansPhiladelphia ChromosomeMyeloproliferative neoplasmMyeloproliferative Disordersbusiness.industryCase-control studyCancerfood and beveragesMyeloproliferative neoplasmssecond cancersarterial eventsNeoplasms Second PrimaryThrombosisCell BiologyHematologyOdds ratioArteriesmedicine.diseasesecond cancersThrombosisSettore MED/15 - MALATTIE DEL SANGUEarterial events030220 oncology & carcinogenesisCase-Control StudiesMultivariate Analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSkin cancerbusiness030215 immunologyFollow-Up StudiesBlood
researchProduct

Comparison between statistical and fuzzy approaches for improving diagnostic decision making in patients with chronic nasal symptoms

2014

This paper compares a fuzzy model, expressed in rule-form, with a well known statistical approach (i.e. logistic regression model) for diagnostic decision making in patients with chronic nasal symptoms. The analyses were carried out using a database obtained from a questionnaire administered to 1359 patients with nasal symptoms containing personal data, clinical data and skin prick test (SPT) results. Both the fuzzy model and the logistic regression model developed were validated using a data set obtained from another medical institution. The accuracy of the two models in identifying patients with positive or negative SPT was similar. This study is a preliminary step to the creation of a so…

medicine.medical_specialtyLogistic regression modelSettore MED/09 - Medicina InternaSkin prick testLogicFuzzy inference systemFuzzy modelPrimary careSettore MED/10 - Malattie Dell'Apparato RespiratorioFuzzy relationLogistic regressionMachine learningcomputer.software_genreFuzzy logicSettore SECS-S/06 -Metodi Mat. dell'Economia e d. Scienze Attuariali e Finanz.Artificial IntelligenceFuzzy modelmedicineIn patientMathematicsNasal symptombusiness.industryApproximate reasoningTest (assessment)Data setPhysical therapyArtificial intelligenceDiagnostic decision makingbusinesscomputerNasal symptomsFuzzy Sets and Systems
researchProduct

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw.

2013

Intravenous bisphosphonates (BP) play a key role in the treatment of bone metastases. As a long-term side effects BP, a form of avascular osteonecrosis of the jaw has been reported. Although, invasive oral local procedures are often present in clinical history of patients suffering from bisphosphonates-related osteonecrosis of the jaws (BRONJ), about up to 50% of BRONJ are spontaneous. We report a case of a 68-year-old female with a spontaneous wide bone sequestration of the left mandibular body onset after infusion of zoledronic acid for 18 cycles for osseous metastasis due to metastatic anaplastic thyroidal carcinoma. Surprisingly the clinical aspects of the patient initially reminded us …

medicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentBone NeoplasmsZoledronic AcidBone sequestrationstomatognathic systemMandibular bodySettore MED/28 - Malattie OdontostomatologichemedicineCarcinomaHumansMandibular DiseasesThyroid Neoplasmsthyroidal carcinomaGeneral DentistryAgedPhossy jawBone Density Conservation AgentsDiphosphonatesbusiness.industryCarcinomaMandibleImidazolesBisphosphonatesGeneral MedicineBisphosphonatemedicine.diseaseBisphosphonatesbisphosphonates‑related osteonecrosis of the jaws thyroidal carcinoma zoledronic acidbisphosphonates-related osteonecrosis of the jawsSurgerylcsh:RK1-715stomatognathic diseasesZoledronic acidlcsh:DentistryBisphosphonate-Associated Osteonecrosis of the JawFemaleOsteonecrosis of the jawbusinessmedicine.drugFollow-Up Studies
researchProduct

Patent Foramen Ovale and Thromboembolic Complications

2010

The foramen ovale, an atrial septal defect which is essential in the fetal circulation, remains patent through adulthood in approximately 25% of the general population and so it represents the most common persistent abnormality of fetal origin. Patent foramen ovale (PFO) allows interatrial right-to-left blood shunting during those periods of the cardiac cycle in which the right atrial pressure exceeds the left one. An increasing number of pathological manifestations of PFO has been recently identified; among these, paradoxical systemic embolism, refractory hypoxemia in patients with right ventricular myocardium infarction or severe pulmonary disease, orthostatic oxygen desaturation in the r…

medicine.medical_specialtyMagnetic Resonance SpectroscopyPopulationEchocardiography Three-DimensionalForamen secundumForamen Ovale PatentPersistent fetal circulationHypoxemiaPFOThromboembolismDrug DiscoverymedicineHumanseducationForamen ovale (heart)Pharmacologyeducation.field_of_studybusiness.industrySettore MED/23 - Chirurgia Cardiacamedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosisSurgerymedicine.anatomical_structureEmbolismEchocardiographyPatent foramen ovalemedicine.symptomTomography X-Ray ComputedbusinessEchocardiography TransesophagealCurrent Pharmaceutical Design
researchProduct

Novel non-invasive Adjunctive Techniques for Early Oral Cancer Diagnosis and Oral Lesions Examination

2012

Oral cancer is a potentially fatal disease with an increasing incidence and an unchanged 5-year mortality rate. Unfortunately, oral cancer is often still late diagnosed, which leads to an increase in the likelihood of functional impairment due to treatment and mortality rate. Definitive diagnosis of oral cancer must be confirmed by scalpel biopsy and histological assessment. However despite its benefits, scalpel biopsy is invasive and it is burdened by a potential morbidity. Furthermore, previous studies have suggested a high degree of intraobserver and interobserver variability regarding the histological evaluation of malignancy. As a consequence, in recent years there has been a growing a…

medicine.medical_specialtyMalignancyNarrow Band ImagingOral cancer potentially malignant disorder early diagnosis screening vital staining autofluorescence chemiluminescence narrow band imaging exfoliative cytology oral biopsySettore MED/28 - Malattie OdontostomatologicheDrug DiscoveryBiopsymedicineHumansMass ScreeningEarly Detection of CancerMass screeningPharmacologyMouth neoplasmNarrow-band imagingStaining and Labelingmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Mortality rateOptical ImagingCancermedicine.diseaseSurgeryLuminescent MeasurementsMouth NeoplasmsRadiologybusinessPrecancerous ConditionsCurrent Pharmaceutical Design
researchProduct

American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to ref…

2009

With reference to the 2009 update of the American Association of Oral and Maxillofacial Surgeons posi- tion paper, Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ), a relevant modification to the previous classification has been made and a new stage (0) added. The latter stage has been defined as “patients with no clinical evidence of necrotic bone, but who present with nonspecific symptoms or clinical and radiographic findings . . .” and the need for various clinical and radiologic aspects in defining this condi- tion was confirmed. .

medicine.medical_specialtyMaxillofacial surgeonsbusiness.industryGeneral surgerymedicine.medical_treatmentAssociation (object-oriented programming)MEDLINEBisphosphonateOtorhinolaryngologySettore MED/28 - Malattie OdontostomatologichePosition paperMedicineSurgeryOral SurgerybusinessBisphosphonates Osteonecrosis Jaws
researchProduct

Measles and Brugada pattern: A case report

2013

No abstract available

medicine.medical_specialtyMeasles Brugadabusiness.industrymedicine.diseaseMeaslesSettore MED/11 - Malattie Dell'Apparato CardiovascolareSudden cardiac deathInternal medicineBrugada patternmedicineCardiologyCardiology and Cardiovascular MedicinebusinessBrugada syndrome
researchProduct

Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)

2012

Dear Editor, It is the authors’ belief that the internationally accepted definition of bisphosphonate-related osteonecrosis of the jaws (BRONJ) (Ruggiero et al, 2009) has several limitations that prevent clinicians from being confident with the diagnosis of the disease. Following recognition of the non-exposed BRONJ clinical variant (Lazarovici et al, 2009), we all became aware that the presence of ‘exposed necrotic bone in the oral cavity’, as outlined in the American Association of Oral and Maxillofacial Surgery (AAOMS) case definition, is just one of the possible clinical manifestations of BRONJ and is not found in all BRONJ patients. As ‘bone exposure’ is certainly not the initial sign …

medicine.medical_specialtyMedullary cavityBone diseaseBiopsymedicine.medical_treatmentSettore MED/29 - Chirurgia MaxillofaccialeDiagnosis DifferentialSettore MED/28 - Malattie OdontostomatologicheTerminology as TopicOral and maxillofacial pathologymedicineHumansGeneral DentistryBisphosphonate-associated osteonecrosis of the jawBone Density Conservation AgentsDiphosphonatesbusiness.industryDecision TreesBisphosphonatemedicine.diseaseSurgeryOtorhinolaryngologybisphosphonate-related osteonecrosis of the jawOral and maxillofacial surgeryBisphosphonate-Associated Osteonecrosis of the JawDifferential diagnosisOsteonecrosis of the jawbusiness
researchProduct